Expert Advice 11 Oct 2024
How to build your biotech company in 2024 (according to founders)
Discover the insight successful biotech founders share with us to build your biotech company – from building your team to attracting funding.
- Latest Posts
News and Trends 10 Oct 2024
Second biotech IPO boom of the year: what does it mean for the industry?
Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry.
Best in Biotech 10 Oct 2024
12 biotech unicorns revolutionizing the future of healthcare
Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the biopharma industry.
In Depth 9 Oct 2024
Promising cure for COPD: Is a breakthrough treatment within reach?
Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease.
In Depth 8 Oct 2024
Top biotech deals of September 2024
There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month.
How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors
Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and paving the way for innovative treatments.
ADVERTISEMENT
ADVERTISEMENT
In Depth 7 Oct 2024
Spinal cord injury: Are we getting closer to a treatment?
Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.
In Depth 4 Oct 2024
The biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.
Podcast 4 Oct 2024
Targeting telomerase to disrupt cancer
Listen to our conversation with Vlad Vitoc, CEO of MAIA, on the pioneering approach of telomere targeting
Best in Biotech 3 Oct 2024
Six biotechs driving progress in Duchenne muscular dystrophy
In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space.
News and Trends 3 Oct 2024
Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.
News and Trends 2 Oct 2024
Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder
Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.
ADVERTISEMENT
